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Background: Although there are plausible mechanisms of female hormones in depression, epidemiolo-
gical evidence has shown conﬂicting results.
Objective: This study aimed to evaluate the associations between female hormonal events and post-
menopausal depression and further investigate the relative association between the age of menarche, the
age of menopause and depression.
Methods: Among 111,589 women who took part in the Health Examinees (HEXA) Study, a total of 60,114
postmenopausal participants were included in the ﬁnal analysis. Each participant provided information
on depression and questions related to reproductive history. The outcome variable was self-reported by
the history of depression diagnosed by physicians and the Center for Epidemiologic Studies Depression
Scale (CES-D) score. With the multivariate logistic regression, odds ratios were calculated. Possible in-
teractions between depression prevalence and the ages of menarche and menopause were assessed.
Results: A total of 2.2% (1342/60,114) women were diagnosed with depression after menopause, and 5.9%
(500/8472) showed depressive symptoms. As the age of menopause and duration of reproductive years
increased, the odds ratio of depression decreased (P-trend o0.001). As the age of menarche increased,
the likelihood of physician-diagnosed depression also increased (P-trend 0.048). As the number of both
spontaneous and induced abortions increased, the odds ratio of depression increased (P-trend o0.001).
Limitation: it is possible that women show inaccuracies in recalling their hormonal events and re-
porting other past mental disorders as depression.
Conclusion: Both the ages of the initiation and the termination of menstruation were associated with the
increased odds ratio of post-menopausal depression. However, the age of menopause seems to be more
important.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Based on the results of the Global Burden of Disease Study
2010, major depressive disorders contributed approximately 8.1%
of years lived with disability (YLD), which became one of the four
leading reasons for disease burden worldwide (Vos et al., 2012).
Around 16.2% of the U.S. adults were found to have major de-
pression in their lifetime in the National Comorbidity Survey Re-
plication (NCS-R) done in 2001–2002 (Kessler et al., 2003), andB.V. This is an open access article u
ive Medicine, Seoul National
-gu, Seoul, 110-799, Republicapproximately 20.1% people stated that they had depressive
symptoms on the Patient Health Questionnaire with 9 items (PHQ-
9) in the National Health and Nutrition Examination Survey
(NHANES) (Shim et al., 2011). It is known that women show higher
prevalence of depression than men, and the female-to-male ratio
of depression is approximately 2:1 (Bebbington, 1998; Kessler,
2003). In Korea, the results appear to follow this trend Cho and Lee
(2005). Several studies suggest that this difference in trend by sex
initiates at puberty and remains until the end of menstruation in
women (Ge et al., 2001; Soares and Zitek, 2008).
Some studies hypothesized that puberty itself increases the risk
for depression, as it is related to the change in the level of sex hor-
mones (Angold et al., 1999; Cyranowski et al., 2000; Opoliner et al.,
2014; Steiner et al., 2003). Additionally, womenwith socio-emotionalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Selection for the participants for the analysis.
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sensitive to stressors around them, which may cause differences (Ge
et al., 1996; Joinson et al., 2011). As a consequence, some studies
assumed that early menarche may occupy an important role in de-
veloping depression and have described a positive association be-
tween early menarche and later depression (Joinson et al., 2011).
However, the results are not consistent. Many studies have reported
that there is no signiﬁcant association between early menarche and
depressive symptoms in later adulthood (Boden et al., 2011; Opoliner
et al., 2014). However, there are ﬁndings contrary to the results of the
previous studies, in which a signiﬁcant association between delayed
menarche and later depression has been found (Herva et al., 2004).
Compared with numerous ﬁndings regarding age of menarche
and depression, relatively few studies have focused on the asso-
ciation between menopausal age and depression. However, the
results seem to be more consistent in association between the age
of menopause and depression. A study conducted in a nationwide
sample of Koreans reported a signiﬁcant decreasing trend in pre-
valence of depression as the age of menopause increased (Jung
et al., 2015). Similarly, the results from a study conducted in France
showed that earlier menopause increased the risk of later de-
pression with a linear trend (Ryan et al., 2008). Menopause brings
hormonal transitions as well as menarche, and it is known that
people with depression in the post-menopausal period show de-
creased serotonin and estradiol concentrations that change the
neurotransmitter activity in the central nervous system (CNS) in
women (Andrade et al., 2005).
Additionally, as multiple studies were conducted in regard to
other reproductive events of women and depression, the results
are still conﬂicting. Contrary to the evidence of pregnancy being
harmful to major depression (Cohen et al., 2006), many studies
have reported no associations between these two factors, includ-
ing the result from Korea (Jung et al., 2015). Similarly, a meta-
analysis of 26 studies suggested that there is a protective effect of
hormone replacement therapy (HRT) against depression (Zweifel
and O’Brien, 1997). However, the opposite result was found in a
recent study conducted in a nationwide sample in Korea (Jung
et al., 2015).
We aim to evaluate the association between various female-
hormonal life events and the prevalence of post-menopausal de-
pression in a large population and, further, to investigate the re-
lative associations between the ages of menarche and menopause
and depression.2. Materials and methods
2.1. Study population
The participants of the study were from the Health Examinees
(HEXA) Study. A main purpose of the HEXA study was to in-
vestigate the epidemiologic characteristics of major chronic dis-
eases in a Korean population (Health Examinees Study, 2015). In
35 major hospitals and local health examination centers, subjects
were recruited with strict selection criteria to fulﬁll representa-
tiveness. Although the HEXA study was designed as a community
based prospective cohort study with its large-scale, only the
baseline data were available in the point of analysis. A total of
170,078 participants from 2004 to 2012 who were aged 35 to 74
years old participated in the study at baseline. With standardized
interviews with trained staff, womenwere requested to respond to
the questionnaire for information on general factors including
socio-demographic items, past medical history, family medical
history, drug use and lifestyle factors. Reproductive and hormone
related factors were additionally asked only in women. Additional
information from the HEXA study is provided elsewhere (HealthExaminees Study, 2015).
The total number of women at baseline was 111,589. Among
them, we excluded 44,727 women who were not menopausal and
1563 women with unknown menopausal status. In women with
menopause, we excluded women with no information on age of
menopause (n¼2659). Women without valid age of menarche
were also excluded (n¼1503). To conﬁrm later depression status,
we excluded women with incomplete data on depression diag-
nosis (n¼253) and those who have an earlier depression diagnosis
age than menopause age (n¼765). The ﬁnal total of women used
in the analysis was 60,114 (Fig. 1).
2.2. Measurement
In measuring depression status, we applied two measures:
(1) past history of depression diagnosed by a physician and
(2) Center for Epidemiologic Studies Depression (CES-D), a psy-
chometric instrument which was translated and modiﬁed to a
Korean version Cho and Kim (1993). If a participant reported a past
depression diagnosis conﬁrmed by physicians, she was also in-
terviewed about the exact age at which she was diagnosed with
depression. Although the past history of depression was recorded
in all participants across the entire study period, CES-D scales
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2009. In the validation study of the CES-D Korean version, the
optimal cutoff point was suggested to be 21 for the community
epidemiological research in Korea (Cho and Kim, 1993), whereas a
cutoff point of 16 is commonly used in Western society (Radloff,
1977). We applied a CES-D score of 21 and over to indicate de-
pressive symptoms.
The total reproductive years were calculated as the duration
between the age at menarche and the age at menopause. In women
who experienced more than one pregnancy, duration between
menarche and ﬁrst pregnancy was computed. As menopause was
categorized as natural or artiﬁcial, abortion was also classiﬁed as
spontaneous or artiﬁcial. Using the number of spontaneous abor-
tions and artiﬁcial abortions, the total number of abortions was
calculated. Factors in regard to menarche, menopause, pregnancy,
abortion, childbirth and breastfeeding were grouped as endogenous
hormonal factors. For exogenous hormonal factors, information on
oral contraceptive and hormone replacement therapy usage and
duration was applied.
Within interviews, information on age at baseline, education
attainment years, household income, marital status, alcohol con-
sumption, and usual exercise frequency was obtained.
2.3. Statistical analysis
To compare the general characteristics between the groups
with and without depression, we conducted χ2 tests. All con-
tinuous variables were categorized into 4 groups, except house-
hold income, number of spontaneous abortions and total child-
births due to their distribution. The age of menarche and age of
menopause was also categorized into 4 groups, following the
distribution in the sample. The median age of menarche (15.5
years) and menopause (50.5) were similar to known age of me-
narche (Cho et al., 2010) and age of menopause (Ministry of Health
and Welfare, 1996) among Korean population considering the
birth year of the participants. We conducted a likelihood ratio test
to select the most appropriate covariate for the model. Possible
confounders such as age, education, marital status, alcohol con-
sumption, exercise and comorbidity were tested, and factors in-
cluding age, education and marital status were selected as cov-
ariates in the ﬁnal model. We performed multivariate logistic re-
gression to evaluate the association between each female re-
productive factor and past depression diagnosed by a physician.
Similarly, a logistic regression was conducted for depressive
symptoms categorized by CES-D score which represents the cur-
rent (baseline) depression status of the participants. By applying
the order of categories, tests for trend were conducted. A sensi-
tivity analysis was performed by excluding those patients who had
already had a depression diagnosis in the past.
To examine the relative magnitude of association between
menarche and menopause with depression, a total of 16 cells were
compared with the 4 categories of age of menarche and meno-
pause. The youngest category was set as the reference group. The
trend tests were performed within the same row or column.
Comparison of age of menarche and menopause with reproductive
years was performed in the same way.
All statistical analyses were conducted using SAS version 9.3
(SAS Institute Inc., Cary, NC, USA). A P-value less than 0.05 was set
as the level of signiﬁcance.
2.4. Ethics
In HEXA, the written consents were provided by all participants
at the baseline survey. As HEXA data are publicly open for use, the
Institutional Review Board of the Seoul National University Hos-
pital, Seoul, Korea approved it for statistical analysis (IRB No.E-1503-103-657).3. Results
3.1. Characteristics of the study subjects
Among 60,119 women with menopause, 1342 women (2.2%)
were reported by physicians to have been diagnosed with de-
pression. The mean age of women with depression was 58.8 years,
whereas women without depression had a mean age of 57.4 years.
Among the 8472 menopausal women in the 2009 survey, 500
women (5.9%) showed depressive symptoms (CES-D score Z21).
The mean ages of women with and without depressive symptoms
were 57.1 years and 57.3 years, respectively. Among the partici-
pants who underwent CES-D tests, those who reported to have a
previous depression diagnosis by a physician had a mean CES-D
score of 13.3, whereas participants without depression had a mean
score of 5.07, and there was a signiﬁcant difference across the two
groups (Po0.001).
Women who were diagnosed with depression comprised a
larger proportion in the lower education group (9.5% vs. 6.9% in
education attainment o6 years). A large proportion of women
without depression were married without separation or divorce
(82.7% w. 78.2%). Women with a depression history tended to rate
their health as “ very bad” (6.6% vs. 1.4%), and approximately 10.8%
of women with depression reported to have 2 or more comorbid
diseases compared with 3.8% of women without depression
(Table 1).
3.2. Association of hormonal events and depression diagnosed by
physician
In Table 2, the results of the multivariable analysis are shown.
In a crude analysis, womenwith later menarche tended to show an
increased likelihood of depression contrary to the women who
experienced their menarche at age 14 or under (P-trend 0.003). In
the adjusted model, this trend was also signiﬁcant, but only wo-
men who had their menarche at age 16 showed a signiﬁcantly
increased likelihood of depression diagnosis (OR 1.23, 95% CI 1.04–
1.44, in full model).
Compared with women who underwent their menopause at
age 47 or younger, gradually decreased likelihoods of depression
were observed as age of menopause increased (P-trend o0.001 in
crude and in full model). When women had menopause at age 53
or older, the odds ratio for depression was 0.45 (95% CI 0.38–0.53)
compared with women with menopause at age 47 or younger in
the fully adjusted model. Similarly, compared with the women
with 31 reproductive years or less, the odds ratio decreased gra-
dually as the total reproductive years extended. Women with 38
years or more between menarche and menopause showed an or of
0.43 (95% CI 0.36–0.51) in the fully adjusted model. In women who
experienced menopause by artiﬁcial procedures such as oophor-
ectomy, the likelihood of depression diagnosis increased with an
OR of 1.61 (95% CI 1.41–1.83) in the model with full adjustment
compared with natural menopause.
Women who ever experienced pregnancy showed a reduced
likelihood of depression (OR 0.72, 95% CI 0.48–1.08); however, the
results were only marginally signiﬁcant. In a crude model, women
with a longer duration between menarche and ﬁrst pregnancy
showed a signiﬁcantly decreased likelihood compared with
6 years or less duration (for women with Z12 years of duration,
OR 0.76, 95% CI 0.64–0.89, P-trend o0.001). This trend was also
signiﬁcant in the fully adjusted model, with marginal signiﬁcance
in strata with longest duration (OR 0.84, 95% CI 0.70–0.99).
As the number of total abortions, including both spontaneous
Table 1
Characteristics of post-menopausal women who ever had menstruation stratiﬁed
by depression using the Health Examinees Study (HEXA) 2004–2012.
Never diagnosed
depression
Post-menopausalonset
depression
p-value
(n¼58,777,
97.8%)
(n¼1342, 2.2%)
General factors N (%) N (%)
Age (years) o0.001
r52 13,557 (23.1) 229 (17.1)
53–56 14,549 (24.8) 272 (20.3)
57–61 14,852 (25.3) 357 (26.6)
461 15,819 (26.9) 484 (36.1)
Education attainment
(years)a
o0.001
o6 4062 (6.9) 127 (9.5)
6–8 14,108 (24.0) 382 (28.5)
9–11 13,009 (22.1) 321 (23.9)
Z12 26,760 (45.5) 505 (37.6)
Familial income (per
month)
o0.001
o$1000 9737 (20.1) 316 (28.2)
$1000–$1999 12,541 (25.9) 324 (28.9)
$2000–$3999 18,292 (37.7) 347 (31.0)
$4000–$5999 5299 (10.9) 93 (8.3)
Z$6000 2610 (5.4) 40 (3.6)
Marital Status o0.001
Never married 722 (1.2) 12 (0.9)
Married-living apart 9222 (15.7) 276 (20.6)
Married or cohabited-
living together
48,597 (82.7) 1049 (78.2)
Alcohol consumption o0.001
Never drinker 43,094 (73.3) 967 (72.1)
Past drinker 1136 (1.9) 48 (3.6)
Current drinker 14,312 (24.4) 323 (24.1)
Usual exercise
frequency
0.023
No 28,249 (48.1) 618 (46.1)
1–2/week 6339 (10.8) 144 (10.7)
3–4/week 11,108 (18.9) 282 (21.0)
5–6/week 6211 (10.6) 127 (9.5)
Everyday 5529 (9.4) 150 (11.2)
Self-rated health o0.001
Very good 914 (1.6) 7 (0.5)
Good 17,803 (30.3) 203 (15.1)
Fair 26,506 (45.1) 475 (35.4)
Bad 12,295 (20.9) 558 (41.6)
Very bad 808 (1.4) 89 (6.6)
Number of
comorbitiesa
o0.001
None 44,158 (75.2) 809 (60.5)
1 12,319 (21.0) 384 (28.7)
2þ 2213 (3.8) 145 (10.8)
2. Each income amount in quartile is different by age strata.
3. Number of comorbidities were calculated from diseases such as myocardial in-
farct, cerebrovascular disease, diabetes mellitus, peptic ulcer disease, liver disease
and any form of cancers.
a Sum of numbers can miss the total number in group due to missing values.
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grew. If women had 3 or more abortions, the likelihood of de-
pression increased with an OR of 1.62 (95% CI 1.39–1.90) in the
fully adjusted model (data not shown). This trend was similarly
found when analyzing both spontaneous abortions and artiﬁcial
abortions separately (both P-trend o0.001). In women who ex-
perienced two or more spontaneous abortions, the OR increased
by 1.77 (95% CI 1.46–2.15). In regard to artiﬁcial abortion, the
likelihood of depression increased by approximately 62% (95% CI
1.40–1.88) in woman who had 3 or more artiﬁcial abortions. The
results regarding the ﬁrst birth age or the last birth age showed no
signiﬁcance (results not shown). Compared with women who had
either zero or one breastfed children, the likelihood of depressiondecreased by an OR of 0.81 (95% CI 0.65–1.00) if women had 4 or
more breastfed children. However, there were no signiﬁcant
trends in the duration of breastfeeding and depression (results not
shown).
In regard to oral contraceptive usage, the OR increased sig-
niﬁcantly in former users compared with those who never used
contraceptives (OR 1.15, 95% CI 1.02–1.31). However, there was no
signiﬁcant results in comparing groups by age at initiation of oral
contraceptive or the duration of oral contraceptive usage (results
not shown). In HRT after menopause, the likelihood of depression
increased signiﬁcantly both in the former user group (OR 1.87, 95%
CI 1.65–2.12) and current user group (2.36, 95% CI 1.97–2.84). In
HRT users, women who took HRT for 41 months or more showed
increased likelihood of depression (OR 1.28, 95% CI 1.00–1.65)
compared to women who had HRT approximately 4 months or
less.
3.3. Association of hormonal events and depressive symptoms eval-
uated with CES-D
In Table 3, the association between each reproductive factor
and depressive symptoms measured by CES-D is shown. There
were no signiﬁcant differences in the fully adjusted model for age
at menarche. Regarding age of menopause, women who had me-
nopause at age 51–52 showed a signiﬁcant decreased OR (OR 0.63,
95% CI 0.47–0.83 in fully adjusted model). The results were similar
with reproductive years. In women who had 38 years or more of
reproductive years, the OR was 0.74 (95%, 0.55–0.99).
Other results were similar to Table 2, and the interval between
menarche and the ﬁrst pregnancy showed a more signiﬁcant trend
(P-trend 0.005 in the full model). The likelihoods of depression
decreased as the interval between menarche and the ﬁrst preg-
nancy increased. In women who had an interval of 12 years or
longer, the likelihood of depression decreased to an OR of 0.68
(95% CI 0.51–0.90). Additionally, as the likelihood of depression
was higher in current HRT users (OR 2.36, 95% CI 1.97–2.84)
compared with former users (OR 1.87, 95% CI 1.65–2.12) as deﬁned
by a physician's diagnosis (Table 2), the likelihood of depression in
current HRT users was lower and insigniﬁcant (OR 1.14, 95% CI
0.78–1.65) compared with the likelihood in former users (OR 1.46,
95% CI 1.16–1.82) according to the CES-D results.
In the sensitivity analysis, the results were very similar if we
excluded the participants who had a prior history of depression
diagnosis (data not shown).
3.4. Association of joint probability of menarche and menopause
Table 4 showed the association of depression and joint prob-
ability with menarche and menopause. In every group with dif-
ferent age of menarche, the likelihood of depression signiﬁcantly
decreased as the age of menopause increased (all, P-trend
o0.001). When groups were restricted to the same menopause
age, there was no signiﬁcant decreasing trend observed as the age
of menarche changed, except for the groups who had menopause
at age 53 or older. The results were similar when comparing the
age of menarche and reproductive years.4. Discussion
In this study, a longer interval between menarche and meno-
pause showed a decreased likelihood with post-menopausal de-
pression deﬁned by both a previous diagnosis by a physician and a
psychometrical approach using the CES-D. Later menarche and
earlier menopause were both associated with post-menopausal
depression. According to the results of the CES-D, the likelihood of
Table 2
Association between each reproductive factors and post-menopausal onset depression by self-reported physician's diagnosis in Health Examinees Study (HEXA) 2004–2012.
Variables No. of control No. of depression Odds ratio age adjusted (95% CI) Odds ratioa multivariable adjusted (95% CI)
Endogenous hormonal factors
Menarche age (years)
r14 16,438 308 1.00 (Ref) 1.00 (Ref)
15 12,488 263 1.08 (0.91–1.27) 1.06 (0.90–1.25)
16 11,812 307 1.28 (1.09–1.50) 1.23 (1.04–1.44)
Z17 18,039 464 1.22 (1.05–1.41) 1.14 (0.98–1.33)
P-trend 0.003 0.048
Menopause age (years)
r47 16,320 492 1.00 (Ref) 1.00 (Ref)
48–50 17,567 421 0.75 (0.66–0.86) 0.76 (0.66–0.86)
51–52 11,529 207 0.55 (0.46–0.65) 0.55 (0.47–0.65)
Z53 13,361 222 0.45 (0.38-0.53) 0.45 (0.38–0.53)
P-trend o0.001 o0.001
Reproductive years (years)
r31 16,321 519 1.00 (Ref) 1.00 (Ref)
32–34 14,351 348 0.75 (0.65–0.86) 0.75 (0.66–0.86)
35–37 16,587 302 0.55 (0.48–0.64) 0.56 (0.48–0.65)
Z38 11,518 173 0.41 (0.35–0.49) 0.43 (0.36–0.51)
P-trend o0.001 o0.001
Type of menopause
Natural 45,507 964 1.00 (Ref) 1.00 (Ref)
Artiﬁcial 10,708 319 1.59 (1.39–1.81) 1.61 (1.41–1.83)
Pregnancy
Never 1350 33 1.00 (Ref) 1.00 (Ref)
Ever 57,417 1309 0.88 (0.62–1.25) 0.72 (0.48–1.08)
Duration between menarche and ﬁrst pregnancy among ever pregnant women (years)
0–6 12,262 345 1.00 (Ref) 1.00 (Ref)
7–9 16,496 386 0.87 (0.75–1.01) 0.91 (0.78–1.06)
10–11 11,636 253 0.84 (0.71–0.99) 0.91 (0.76–1.08)
Z12 16,108 305 0.76 (0.64–0.89) 0.84 (0.70–0.99)
P-trend o0.001 0.054
Number of spontaneous abortionb among ever pregnant women
0 44,291 945 1.00 (Ref) 1.00 (Ref)
1 8799 213 1.13 (0.97–1.31) 1.13 (0.97–1.31)
Z2 3226 121 1.77 (1.46–2.15) 1.77 (1.46–2.15)
P-trend o0.001 o0.001
Number of artiﬁcial abortion among ever pregnant women
0 18,782 357 1.00 (Ref) 1.00 (Ref)
1 13,270 291 1.18 (1.00–1.37) 1.19 (1.02–1.40)
2 11,850 238 1.07 (0.91–1.27) 1.10 (0.93–1.29)
Z3 11,771 374 1.61 (1.39–1.86) 1.62 (1.40–1.88)
P-trend o0.001 o0.001
Number of total childbirth including abortions among ever parous women
1 4534 104 1.00 (Ref) 1.00 (Ref)
2 26,903 553 0.89 (0.72–1.10) 0.90 (0.73–1.12)
Z3 25,271 638 0.89 (0.71–1.10) 0.85 (0.68–1.06)
P-trend 0.448 0.139
Number of total breastfed children among ever parous women
0-1 11,711 247 1.00 (Ref) 1.00 (Ref)
2 22,873 483 0.98 (0.84–1.14) 0.96 (0.82–1.12)
3 14,196 355 0.99 (0.84–1.17) 0.93 (0.79–1.11)
Z4 7764 201 0.91 (0.74–1.11) 0.81 (0.65–1.00)
P-trend 0.437 0.062
Exogenous hormonal factors
Oral contraceptive usage
Never user 46,102 1,006 1.00 (Ref) 1.00 (Ref)
Former user 12,176 328 1.18 (1.04–1.34) 1.15 (1.02–1.31)
Current user 109 4 1.60 (0.59–4.34) 1.59 (0.59–4.34)
Hormone usagec
Never user 41,986 772 1.00 (Ref) 1.00 (Ref)
Former user 10,776 376 1.83 (1.62–2.08) 1.87 (1.65–2.12)
Current user 3635 144 2.33 (1.94–2.79) 2.36 (1.97–2.84)
Duration of hormone replacement therapy (months) among ever usersc
r4 3533 121 1.00 (Ref) 1.00 (Ref)
5-15 3429 106 0.90 (0.69–1.18) 0.93 (0.82–1.22)
16-40 3435 117 0.99 (0.76–1.28) 1.03 (0.80–1.34)
Z41 3364 143 1.21 (0.94–1.55) 1.28 (1.00–1.65)
P-trend 0.097 0.035
a Adjusted with age, education and marital status.
b Miscarriage before the 20th week of pregnancy. Delivering a baby born with no signs of life at or after 20 weeks' gestation.
c Only the data from HEXA 2005–2012 was used due to lack of information.
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Table 3
Association between each reproductive factors and women with depressive symptom (CES-D scoreZ21) among women who completed CES-D in Health Examinees Study
(HEXA) 2009.
Variables No. of control No. of depression Odds ratio age adjusted (95% CI) Odds ratioa multivariable adjusted (95% CI)
Endogenous hormonal factors
Menarche age (years)
r14 2187 126 1.00 (Ref) 1.00 (Ref)
15 1642 81 0.86 (0.65–1.15) 0.85 (0.63–1.13)
16 1585 98 1.10 (0.83–1.44) 1.05 (0.79–1.38)
Z17 2558 195 1.36 (1.07–1.72) 1.21 (0.95–1.55)
P-trend 0.003 0.054
Menopause age (years)
r47 2110 163 1.00 (Ref) 1.00 (Ref)
48-50 2489 159 0.83 (0.66–1.04) 0.83 (0.66–1.05)
51-52 1618 76 0.62 (0.46–0.82) 0.63 (0.47–0.83)
Z53 1755 102 0.77 (0.59–1.01) 0.79 (0.60–1.04)
P-trend 0.011 0.020
Reproductive years (years)
r31 2158 159 1.00 (Ref) 1.00 (Ref)
32–34 2035 154 1.04 (0.82–1.30) 1.05 (0.83–1.32)
35-37 2311 114 0.68 (0.53–0.87) 0.72 (0.56–0.93)
Z38 1468 73 0.69 (0.51–0.92) 0.74 (0.55–0.99)
P-trend o0.001 0.004
Duration between menarche and ﬁrst pregnancy among ever pregnant women (years)
0–6 1799 43 1.00 (Ref) 1.00 (Ref)
7–9 2388 52 0.63 (0.50–0.80) 0.71 (0.56–0.92)
10–11 1590 29 0.50 (0.37–0.67) 0.59 (0.43–0.80)
Z12 2231 37 0.56 (0.44–0.73) 0.68 (0.51–0.90)
P-trend o0.001 0.005
Number of spontaneous abortionb among ever pregnant women
0 6243 353 1.00 (Ref) 1.00 (Ref)
1 1100 76 1.22 (0.94–1.57) 1.23 (0.95–1.59)
Z2 333 37 1.96 (1.37–2.80) 2.01 (1.40–2.87)
P-trend o0.001 o0.001
Number of artiﬁcial abortion among ever pregnant women
0 2454 156 1.00 (Ref) 1.00 (Ref)
1 1922 99 0.82 (0.63–1.06) 0.85 (0.66–1.10)
2 1673 90 0.85 (0.65–1.11) 0.89 (0.68–1.17)
Z3 1556 118 1.19 (0.93–1.52) 1.24 (0.96–1.59)
P-trend 0.287 0.161
Exogenous hormonal factors
Oral contraceptive usage
Never user 6320 380 1.00 (Ref) 1.00 (Ref)
Former user 1612 116 1.20 (0.97–1.49) 1.18 (0.95–1.47)
Current user 22 3 2.28 (0.68–7.66) 2.21 (0.65–7.51)
Hormone usagec
Never user 6038 352 1.00 (Ref) 1.00 (Ref)
Former user 1412 112 1.39 (1.11–1.73) 1.46 (1.16–1.82)
Current user 498 33 1.13 (0.78–1.64) 1.14 (0.78–1.65)
Duration of hormone replacement therapy (months) among ever usersc
r4 421 30 1.00 (Ref) 1.00 (Ref)
5–15 460 31 0.95 (0.57–1.60) 0.96 (0.57–1.62)
16–40 477 36 1.08 (0.65–1.79) 1.14 (0.68–1.89)
Z41 490 43 1.26 (0.77–2.06) 1.33 (0.81–2.20)
P-trend 0.289 0.190
a Adjusted with age, education and marital status.
b Miscarriage before the 20th week of pregnancy. Delivering a baby born with no signs of life at or after 20 weeks' gestation.
c Only the data from HEXA 2005–2012 was used due to lack of information.
Table 4
Association of depression and joint probability of menarche, menopause and reproductive years
Menarche age (years) Menopause age (years) P-trend
r46 47–49 50–52 Z53
Case N ORa (95% CI) Case N ORa (95% CI) Case N ORa (95% CI) Case N ORa (95% CI)
r14 132 1.00 (Ref) 85 0.66 (0.50–0.87) 44 0.52 (0.67–0.73) 47 0.51 (0.36–0.72) o0.001
15 95 1.03 (0.79–1.35) 94 0.88 (0.67–1.15) 31 0.73 (0.29–0.64) 43 0.49 (0.35–0.70) o0.001
16 106 1.20 (0.92–1.56) 96 0.94 (0.72–1.23) 55 0.72 (0.52–1.00) 50 0.51 (0.36–0.71) o0.001
Z17 159 1.14 (0.89–1.45) 146 0.84 (0.66–1.08) 77 0.69 (0.52–0.93) 82 0.48 (0.36–0.64) o0.001
P-trend 0.784 0.853 0.433 0.007 P-int 0.525
a Adjusted with age, education and marital status.
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narche and ﬁrst pregnancy increased. There were signiﬁcant as-
sociations between depression and an increasing number of both
total and spontaneous abortions. In HRT, former users showed
signiﬁcantly increased ORs compared to those who never used
HRT.
The mean age of menarche in this study was 15.6 years, and
this ﬁnding was similar to a previous study with nationally re-
presentative data conducted in Korea (Jung et al., 2015). Although
the mean menarche age in this study seems older than the current
Caucasian population, it is consistent with a previous survey in
which approximately 70% of womenwho were born between 1950
and 1959 experienced menarche after age 15 (Park et al., 2006).
The older age of menarche was signiﬁcantly associated with
increased post-menopausal depression diagnosed by physicians.
This ﬁnding is inconsistent with other previous reports suggesting
that women who had earlier menarche show a high risk of de-
pressive symptoms (Joinson et al., 2011; Trepanier et al., 2013).
However, there was a difference in deﬁning ‘early menarche’, as
these prior studies deﬁned 10–11 years as early menarche (Joinson
et al., 2011). In our study, the reference group was women who
had menarche at the age of 14 or younger, whereas studies con-
ducted in Canada and U.K. set the ages 12–13 as the normal me-
narche age (Joinson et al., 2011; Trepanier et al., 2013). A study
conducted in Finland reported to have an increased OR of de-
pression in women who had menarche at age 16 or older com-
pared with women who had menarche at age 12–15 (Herva et al.,
2004). Similarly, a study conducted in the U.S. found an association
between later menarche and increased depressive symptoms after
adjusting for age and other factors (Bisaga et al., 2002).
Compared with menarche, the trend of decreasing ORs with an
increasing age of menopause was more prominent. These results
are coherent with other prior results including studies conducted
in a nationwide sample of the Korean population (Jung et al.,
2015). In Europe and the U.S., the results of studies show the same
relationship (Harlow et al., 2003; Ryan et al., 2008). The associa-
tion between depression and number reproductive years, the in-
terval between menarche and menopause, is very similar to the
relationship between depression and the age of menopause. A
calculation of reproductive years was frequently used to measure
the lifetime exposure to estrogen (Low et al., 2005). A younger age
of menarche and older age of menopause are associated with a
greater total exposure of estrogen. According to the results of the
joint analysis, the age of menopause seems to be a more important
factor in the association with post-menopausal depression, and
the age of menarche becomes a signiﬁcant factor only for women
who experienced late menopause.
As the total number of abortions increased, the likelihood of
depression also increased. This trend was prominent in sponta-
neous abortions in both depression measurements. However, in
regard to artiﬁcial abortions, a signiﬁcant trend was observed only
in physician-diagnosed depression. Most studies reported that no
associations were observed between induced abortions and de-
pression (Boersma et al., 2014), and some systematic reviews
proposed that the results are mostly neutral according to the as-
sociation between induced abortion and depression (Charles et al.,
2008). Most of these studies used psychometrics such as the CES-D
and Brief Symptom Inventory-short form to deﬁne depression.
However, as our results showed a signiﬁcant association between
an increasing number of artiﬁcial abortions and depression, the
most recent meta-analysis on this issue asserts that women with
induced abortion showed an elevated risk of depression (Coleman,
2011).
In exogenous hormone usage, hormone replacement after
menopause was associated with post-menopausal onset depres-
sion. However, the Women's Health Initiative Study of CognitiveAging (WHISCA) which evaluated whether exogenous hormone
use inﬂuence cognitive functions and affect among 1416 post-
menopausal women showed that participants in hormone therapy
arm who received combination of estrogen and progesterone
showed no signiﬁcant change in positive or negative affect and
depressive symptoms (Resnick et al., 2006). In contrary, a study
suggest the protective effect of HRT on depression development
(Schmidt et al., 2000) and a pilot study in Korea demonstrated a
decreased likelihood of depression in HRT users (Lim et al., 2006).
However, there was a signiﬁcant association between HRT use and
depression, and the results of this study coincide with other pre-
vious studies conducted in Europe (Ryan et al., 2008) and Korea
(Jung et al., 2015). In this study, former HRT users showed sig-
niﬁcantly increased odds ratios of depression deﬁned by both
physician diagnosis and CES-D. There was also a signiﬁcant trend
in prevalence of depression diagnosis with increased duration of
HRT. Compared with women who had HRT for 4 months or less,
women who took HRT for 41 months or longer showed an ap-
proximately 30% increase in depression likelihood. However, this
trend with the duration of HRT was not shown when measuring
depression with current CES-D scores. Additionally, as the odds
ratio of depression diagnosed by a physician for current HRT users
was greater than in former users, the magnitude of the odds ratio
decreased in current HRT users compared with former users ac-
cording to the CES-D results. It is possible that there is an inverse
causality in this association, in which womenwith a past history of
post-menopausal onset depression tend to seek more HRT. Be-
cause there is no information for initiation age of HRT, we were
unable to compare with the age of depression diagnosis. Further
research is needed to evaluate this issue.
We used two methods to deﬁne post-menopausal depression:
physician diagnosed depression history and self-reported CES-D
score. CES-D is a 20-item questionnaire measuring the number of
depressive symptoms with its duration (Radloff, 1977). According
to a validation study, it is known that the Korean population tend
to not express their positive feelings, which translates to a higher
standard cutoff point for epidemiologic studies than Western so-
ciety (Cho and Kim, 1993). Using psychometrics such as CES-D is
not exactly the same as a physician's diagnosis. In CES-D original
version, the sensitivity and speciﬁcity was found to be 86 percent
and 90 percent, respectively, with a positive predictive value
showing 80% (Parikh et al., 1988). In the Korean version of the CES-
D, the sensitivity and speciﬁcity was 96 percent and 69 percent,
respectively. Although depression diagnosis by a physician seems
to represent a more valid value of depression, there may be more
ﬂuctuation in deﬁning depression due to personal differences in
experience or knowledge between physicians (Cho and Kim, 1993).
The results were generally similar between these two different
measures of depression.
As longer reproductive years represent extended exposure to
gonadal hormones in women, many publications focus on the role
of estrogen in addition to its effect on mental health. In addition, it
is known that the change in circulating estrogen during puberty is
also related to the disturbances in mood (Susman et al., 1987), and
the estrogen in puberty affects adolescent brain in mice (Sisk and
Zehr, 2005). Estrogen is known to interact with the serotonergic
system and processes related to norepinephrine in post-meno-
pausal women (Halbreich, 1997). Among the receptors for estro-
gen, the beta-receptor plays a major role in emotional processes
associated with the serotonergic system (McEwen, 2001). Estrogen
receptors located in the central nervous system seems to play roles
in cognition and mood (Kruijver et al., 2003). As estrogen lessens
monoamine oxidase, the level of serotonin increases (Sherwin,
1996). As the estrogen was known to be protective in depression,
there are several studies regarding the use of exogenous estrogen
in postpartum depression. One study conducted in U.S. suggested
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(Moses-Kolko et al., 2009). In addition, a meta-analysis also re-
commended to use estrogen therapy to treat severe postpartum
depression (Dennis et al., 2008).
A strength of this study was the large population. As there was
enough power, items such as associations between age of me-
narche and depression were observed with signiﬁcant results. In a
previous study conducted in Korea, such an association was not
signiﬁcant (Jung et al., 2015). All the information was collected
with trained interviewers with a standardized questionnaire. As
the questionnaire contained a large number of exposure in-
formation, it was possible to consider particular covariates, such as
the number of comorbidities or marital status. Additionally, this
study applied two measures to deﬁne depression: past history of
physician diagnosed depression and depressive symptoms deﬁned
by the CES-D score. As the depression diagnosis by physicians
represents depression deﬁned by the Diagnostic and Statistical
Manual of Mental Disorders (DSM) or the International Classiﬁ-
cation of diseases and Related Health Problems (ICD) as the gold
standards, most of the studies used psychometrics alone to eval-
uate depression. The results may vary with these different mea-
sures; however, this study found stable results by comparing the
results of two deﬁnitions.5. Limitations
There are several limitations in this study. The recalled in-
formation of previous hormonal events may be less accurate,
especially for the information of menarche. However, a cohort
study conducted in Korea revealed that the percent agreement
was robust on menarche information even with an error range of
less than 1 year (Ko et al., 2008). Similarly, it is unlikely to have a
differential misclassiﬁcation on reproductive history in this study
by depression diagnosis or CES-D score.
In the HEXA study, there were no items querying the family
history of depression or psychiatric drug usage. Although these
factors are possible confounders, we could not adjust them in the
full model. As it was difﬁcult to interpret the time-sequence in
association with each hormonal factor and depression onset before
menopause, we excluded the women with pre-menopausal de-
pression. Additionally, we excluded women with unknown me-
nopausal statuses, which may cause potential bias.6. Conclusion
Our study found that both ages of menarche and menopause
show increased likelihood of post-menopausal onset depression.
However, the age of menopause seems to be more important in
depression prevalence. Based on our results, we suggest that wo-
men with earlier menopause and increased number of abortions
should be checked for depression carefully. Additionally, further
research is needed to evaluate the true causality between HRT and
depression, especially in Korea.References
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